OBJECTIVES: Analysis of outcomes of a cohort of patients with esthesioneuroblastoma. DESIGN: Retrospective cohort analysis. SETTING: PATIENTS presenting with esthesioneuroblastoma from 1994 to 2006 in a tertiary care academic medical center. PATIENTS: Fifteen consecutive patients diagnosed as having esthesioneuroblastoma were treated during this time period using a subcranial resection. The mean follow-up is 75 months (range, 2 to 240 mos). RESULTS: The overall survival was 100% and the overall disease-free survival was 49% and 24% at 5 and 15 years, respectively. PATIENTS treated with radiation therapy following surgical resection had a 5- and 15-year disease-free survival of 83.3% compared with a 5- and 15-year disease-free survival of 26.7% and 0%, respectively, for patients whose initial treatment was surgery alone. The mean time to recurrence was 82.1 months. None of the patients had a decrease in Karnofsky Performance Score following subcranial resection. CONCLUSIONS: PATIENTS with esthesioneuroblastoma whose initial treatment consists of surgical resection followed by radiation therapy have a longer disease-free survival than patients treated with surgery alone. However, initial treatment modality did not have an effect on survival. Long-term, close follow-up is necessary to identify recurrences, which can be treated with a high degree of success.
OBJECTIVES: Analysis of outcomes of a cohort of patients with esthesioneuroblastoma. DESIGN: Retrospective cohort analysis. SETTING:PATIENTS presenting with esthesioneuroblastoma from 1994 to 2006 in a tertiary care academic medical center. PATIENTS: Fifteen consecutive patients diagnosed as having esthesioneuroblastoma were treated during this time period using a subcranial resection. The mean follow-up is 75 months (range, 2 to 240 mos). RESULTS: The overall survival was 100% and the overall disease-free survival was 49% and 24% at 5 and 15 years, respectively. PATIENTS treated with radiation therapy following surgical resection had a 5- and 15-year disease-free survival of 83.3% compared with a 5- and 15-year disease-free survival of 26.7% and 0%, respectively, for patients whose initial treatment was surgery alone. The mean time to recurrence was 82.1 months. None of the patients had a decrease in Karnofsky Performance Score following subcranial resection. CONCLUSIONS:PATIENTS with esthesioneuroblastoma whose initial treatment consists of surgical resection followed by radiation therapy have a longer disease-free survival than patients treated with surgery alone. However, initial treatment modality did not have an effect on survival. Long-term, close follow-up is necessary to identify recurrences, which can be treated with a high degree of success.
Entities:
Keywords:
Esthesioneuroblastoma; olefactory neuroblastoma; skull base tumor; subcranial
Authors: Eduardo M Diaz; Richard H Johnigan; Colin Pero; Adel K El-Naggar; Dianna B Roberts; James L Barker; Franco DeMonte Journal: Head Neck Date: 2005-02 Impact factor: 3.147
Authors: Marc W Herr; Stacey T Gray; Audrey B Erman; William T Curry; Daniel G Deschler; Derrick T Lin Journal: J Neurol Surg B Skull Base Date: 2013-03-13
Authors: Kyle K VanKoevering; Katayoon Sabetsarvestani; Stephen E Sullivan; Ariel Barkan; Michelle Mierzwa; Erin L McKean Journal: J Neurol Surg B Skull Base Date: 2019-02-21
Authors: Rohan R Joshi; Qasim Husain; Benjamin R Roman; Jennifer Cracchiolo; Yao Yu; Jillian Tsai; Julie Kang; Sean McBride; Nancy Y Lee; Luc Morris; Ian Ganly; Viviane Tabar; Marc A Cohen Journal: J Surg Oncol Date: 2018-11-22 Impact factor: 3.454
Authors: James C Marsh; Shalini Garg; Julie A Wendt; Benjamin T Gielda; Julius V Turian; Arnold M Herskovic Journal: Pituitary Date: 2010-09 Impact factor: 4.107
Authors: Leif Bäck; Minna Oinas; Petra Pietarinen-Runtti; Kauko Saarilahti; Jyrki Vuola; Riste Saat; Juha Öhman; Caj Haglund; Mika Niemelä; Ilmo Leivo; Jaana Hagström; Antti A Mäkitie Journal: Eur Arch Otorhinolaryngol Date: 2011-03-15 Impact factor: 2.503
Authors: Gurvinder Kaur; Ari J Kane; Michael E Sughrue; Michelle Madden; Michael C Oh; Matthew Z Sun; Michael Safaee; Ivan El-Sayed; Manish Aghi; Michael W McDermott; Mitchel S Berger; Andrew T Parsa Journal: J Clin Neurosci Date: 2012-12-21 Impact factor: 1.961
Authors: Aileen Wertz; Todd Hollon; Lawrence J Marentette; Stephen E Sullivan; Jonathan B McHugh; Erin L McKean Journal: J Neurol Surg B Skull Base Date: 2017-08-17